紫杉醇
红豆杉
底盘
生物合成
转化(遗传学)
细胞培养
代谢工程
计算生物学
化学
生物
合成生物学
模块化设计
细胞生物学
生物化学
萜类
紫杉类
普氏藻
作者
Mengkai Zhao,Wenchang Lu,Renhai Peng,Liyan Wang,Ali Raza,Bin Jia,Zhangli Hu
标识
DOI:10.1038/s41467-026-76625-x
摘要
Paclitaxel is a highly valuable diterpenoid anticancer drug originally extracted from the yew tree. Due to the low efficiency of plant extraction and the high cost of semi-synthesis, efforts have been made to produce paclitaxel through biosynthesis. However, there have been no reports to date on engineered strains capable of paclitaxel biosynthesis. Here, we engineer a paclitaxel-producing line using the moss (Physcomitrium patens) chassis cells by combining transient expression verification, cytoplasmic localization strategies, self-cleaving 2 A peptide-mediated multi-gene co-expression systems and a modular iterative transformation strategy for stable genetic inheritance. Even after continuous subculturing multiple times, the engineered paclitaxel-producing lines obtained through both the initial reconstructed pathway and the optimized pathway are able to stably produce paclitaxel. This study proposes that Physcomitrium patens can serve as a plant chassis for paclitaxel biosynthesis.
科研通智能强力驱动
Strongly Powered by AbleSci AI